Abstract
The COVID-19 pandemic has provided an opportunity for repurposing of drugs, including complex, natural drugs, to meet the global need for safe and effective antiviral medicines which do not promote multidrug resistance nor inflate medical costs. The author herein describes his own repurposing of herbal tinctures, previously prepared for oncology, into a possibly synergistic, anti-COVID 41 “herb” formula of extracts derived from 36 different plants and medicinal mushrooms. A method of multi-sample in vitro testing in green monkey kidney vero cells is proposed for testing the Hypothesis that even in such a large combination, antiviral potency may be preserved, along with therapeutic synergy, smoothness, and complexity. The possibility that the formula’s potency may improve with age is considered, along with a suitable method for testing it. Collaborative research inquiries are welcome.
| Original language | English |
|---|---|
| Article number | 12 |
| Journal | Frontiers in Bioscience - Scholar |
| Volume | 14 |
| Issue number | 2 |
| DOIs | |
| State | Published - 6 May 2022 |
Bibliographical note
Publisher Copyright:© 2022 The Author(s). Published by IMR Press.
Keywords
- Peganum harmala
- botanical
- harmine
- licorice
- medicinal mushroom
- synergen
- virucidal
- virus
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology
- General Immunology and Microbiology